PubMed Health⌕ Search

PubMed · 3479818

Effective sample sizes for confidence intervals for survival probabilities.

Abstract

We examine various methods to estimate the effective sample size for construction of confidence intervals for survival probabilities. We compare the effective sample sizes of Cutler and Ederer and Peto et al., as well as a modified Cutler-Ederer effective sample size. We investigate the use of these effective sample sizes in the common situation of many censored observations that intervene between the time point of interest and the last death before this time. We note that there is no a priori reason to treat upper and lower confidence intervals in a symmetric fashion since censored survival data are by nature asymmetric. We recommend the use of the Cutler-Ederer effective sample size in construction of upper confidence intervals and the Peto effective sample size in construction of lower confidence intervals. Two examples with real data demonstrate the differences between confidence intervals formed with different effective sample sizes. This study also illustrates the need for caution in the application of simulation studies to real problems.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

F J Dorey, E L Korn. 1987. Effective sample sizes for confidence intervals for survival probabilities.. https://doi.org/10.1002/sim.4780060605

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Persistent bacterial infections and primary immune disorders.

Mycobacteria, Salmonella and Helicobacter species have all evolved mechanisms to evade host defenses and cause persistent infection in humans. Host control of mycobacteria and Salmonella is largely achieved by the IFN-gamma/IL-12 pathway. Immune disorders affecting this pathway are characterized by disseminated infections with environmental or nontuberculous mycobacteria. Helicobacter is a predominantly extracellular bacterium that uses its remarkable genetic diversity (as well as other mechanisms) in order to evade host defenses. The importance of humoral immunity in containing Helicobacter infections to the mucosal surface is illustrated by the primary immune disorder, X-linked agammaglobulinemia in which patients are prone to chronic bacteremia and skin infections by Helicobacter and related species such as Flexispira and Campylobacter. Exploration of these particular infections in their specific immune defects sheds light on both host and bacterial mechanisms that have implications for pathogenesis and therapy.

Bacterial Infections↗

The importance of vaccination.

We have vaccines for nearly thirty of the more than seventy infectious diseases which are pathogenic for humans. Most of the vaccines, especially those to prevent childhood diseases, are highly effective with a high safety profile. Vaccines are being developed against many of the other bacteria and viruses, and some parasites. Occasionally, a new vaccine has to be withdrawn because of unexpected side effects. Smallpox remains the only infectious disease to have been eradicated. The Global Program to eradicate poliomyelitis initiated in 1988, has unfortunately run into difficulties. A few children immunised with the Sabin oral vaccine fail to clear the virus which can mutate over some years into a pathogenic form and spread rapidly unless large vaccination programs are re-introduced. Of major concern are emerging and re-emerging infectious diseases, especially HIV, for which there is currently no vaccine. Fortunately, new techniques are becoming available making it possible to consider developing vaccines based on inducing strong cell-mediated immune responses to control the agent's replication when antigenic variation in surface antigens (e.g. HIV, influenza) makes classical techniques based on induction of antibody responses less attractive.

Bacterial Infections↗